Neovasc's stock soars 60% premarket after submitting premarket approval application for angina treatment
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

from MarketWatch.com - Real-time Headlines https://ift.tt/2E2AJ5M
via IFTTT
from MarketWatch.com - Real-time Headlines https://ift.tt/2E2AJ5M
via IFTTT
Kommentare
Kommentar veröffentlichen